WallStreetZenWallStreetZen

NASDAQ: ACIU
Ac Immune Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ACIU

Based on 2 analysts offering 12 month price targets for Ac Immune Sa.
Min Forecast
$8.00+167.56%
Avg Forecast
$12.00+301.34%
Max Forecast
$16.00+435.12%

Should I buy or sell ACIU stock?

Based on 2 analysts offering ratings for Ac Immune Sa.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACIU stock forecasts and price targets.

ACIU stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-31
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is ACIU forecast to generate an efficient return?
Company
1.85%
Industry
-388.81%
Market
59.09%
ACIU's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACIU forecast to generate an efficient return on assets?
Company
0.96%
Industry
27.33%
ACIU is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACIU earnings per share forecast

What is ACIU's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.89
Avg 2 year Forecast
$0.01
Avg 3 year Forecast
-$0.34

ACIU revenue forecast

What is ACIU's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$7.7M-55.51%
Avg 2 year Forecast
$105.0M+510.36%
Avg 3 year Forecast
$114.9M+567.66%
ACIU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACIU revenue growth forecast

How is ACIU forecast to perform vs Biotechnology companies and vs the US market?
Company
95.76%
Industry
34.98%
Market
9.26%
ACIU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACIU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACIU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACIU$2.99$12.00+301.34%Strong Buy
EDIT$3.59$10.71+198.44%Buy
LYEL$1.17$3.50+199.15%Buy
TCRX$5.55$12.00+116.22%Strong Buy
VNDA$5.02$13.00+158.96%Strong Buy
View Top Biotech Stocks

Ac Immune Sa Stock Forecast FAQ

Is Ac Immune Sa Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ACIU) stock is to Strong Buy ACIU stock.

Out of 2 analysts, 1 (50%) are recommending ACIU as a Strong Buy, 1 (50%) are recommending ACIU as a Buy, 0 (0%) are recommending ACIU as a Hold, 0 (0%) are recommending ACIU as a Sell, and 0 (0%) are recommending ACIU as a Strong Sell.

If you're new to stock investing, here's how to buy Ac Immune Sa stock.

What is ACIU's earnings growth forecast for 2024-2026?

(NASDAQ: ACIU) Ac Immune Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Ac Immune Sa's earnings in 2024 is -$70,359,302.On average, 3 Wall Street analysts forecast ACIU's earnings for 2024 to be -$88,270,905, with the lowest ACIU earnings forecast at -$93,576,915, and the highest ACIU earnings forecast at -$80,635,427. On average, 3 Wall Street analysts forecast ACIU's earnings for 2025 to be $1,324,014, with the lowest ACIU earnings forecast at -$63,711,942, and the highest ACIU earnings forecast at $34,842,469.

In 2026, ACIU is forecast to generate -$33,846,969 in earnings, with the lowest earnings forecast at -$105,522,905 and the highest earnings forecast at $61,720,944.

What is ACIU's revenue growth forecast for 2024-2026?

(NASDAQ: ACIU) Ac Immune Sa's forecast annual revenue growth rate of 95.76% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.98%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.26%.

Ac Immune Sa's revenue in 2024 is $18,009,302.On average, 3 Wall Street analysts forecast ACIU's revenue for 2024 to be $762,253,661, with the lowest ACIU revenue forecast at $205,072,815, and the highest ACIU revenue forecast at $1,399,771,285. On average, 3 Wall Street analysts forecast ACIU's revenue for 2025 to be $10,456,423,897, with the lowest ACIU revenue forecast at $3,499,477,986, and the highest ACIU revenue forecast at $15,008,144,432.

In 2026, ACIU is forecast to generate $11,437,986,009 in revenue, with the lowest revenue forecast at $3,697,781,407 and the highest revenue forecast at $19,178,290,162.

What is ACIU's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ACIU) forecast ROA is 0.96%, which is lower than the forecast US Biotechnology industry average of 27.33%.

What is ACIU's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ACIU price target, the average ACIU price target is $12.00, with the highest ACIU stock price forecast at $16.00 and the lowest ACIU stock price forecast at $8.00.

On average, Wall Street analysts predict that Ac Immune Sa's share price could reach $12.00 by May 31, 2025. The average Ac Immune Sa stock price prediction forecasts a potential upside of 301.34% from the current ACIU share price of $2.99.

What is ACIU's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ACIU) Ac Immune Sa's current Earnings Per Share (EPS) is -$0.74. On average, analysts forecast that ACIU's EPS will be -$0.89 for 2024, with the lowest EPS forecast at -$0.94, and the highest EPS forecast at -$0.81. On average, analysts forecast that ACIU's EPS will be $0.01 for 2025, with the lowest EPS forecast at -$0.64, and the highest EPS forecast at $0.35. In 2026, ACIU's EPS is forecast to hit -$0.34 (min: -$1.06, max: $0.62).

What is ACIU's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ACIU) forecast ROE is 1.85%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.